MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202527067966 A) filed by Hanmi Pharm. Co. Ltd., Gyeonggi, Republic of Korea, on July 16, for 'formulation containing immunoactive interleukin 2 analog conjugate.'
Inventor(s) include Kim, Sang Yun; Kim, Jeong Woo; Yoo, Nyeong Sang; Lee, Jong Min; Choi, Min Young; and Hong, Sung Hee.
The application for the patent was published on Aug. 8, under issue no. 32/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a formulation containing a long-acting conjugate of an interleukin 2 analog."
The patent application was internationally filed on Dec. 22, 2023, under International application No.PCT/KR2023/021397.
Disclaimer: Curated by HT Syndication.
